Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT).
Journal article
Marcovecchio ML. et al, (2018), Diabetes Care, 41, 1963 - 1969
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.
Other
Clarke RJ. et al, (2018), JAMA Cardiol, 3, 781 - 782
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.
Journal article
Beveridge LA. et al, (2018), J Am Heart Assoc, 7
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
Journal article
Berlanga-Taylor AJ. et al, (2018), EBioMedicine, 31, 133 - 142
Ezetimibe: Likely to Be Beneficial For All.
Other
Herrington WG. et al, (2018), Circulation, 137, 1583 - 1584
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.
Journal article
Bowman L. et al, (2018), Am Heart J, 198, 135 - 144
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Journal article
Aung T. et al, (2018), JAMA Cardiol, 3, 225 - 234
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.
Journal article
Parish S. et al, (2018), Circ Genom Precis Med, 11
Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.
Journal article
Herrett E. et al, (2017), BMJ Open, 7
Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors.
Journal article
Di Angelantonio E. et al, (2017), Lancet, 390, 2360 - 2371
Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D).
Journal article
Tomson J. et al, (2017), J Am Heart Assoc, 6
Genetic approaches to elucidating our understanding of therapeutic targets
Poster
STIBY A. et al, (2017)
Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
Conference paper
Aung T. et al, (2017), EUROPEAN HEART JOURNAL, 38, 426 - 426
The Role of Emerging Risk Factors in Cardiovascular Outcomes.
Journal article
Lacey B. et al, (2017), Curr Atheroscler Rep, 19
Factors influencing recruitment in large randomised trials
Other
Edwards D. et al, (2017), TRIALS, 18
LENS - a clinical trial embedded in routine clinical practice to reduce the burden of diabetic eye disease
Conference paper
Preiss D. et al, (2017), TRIALS, 18
Telephone support for mail based recruitment and follow-up in a large randomized trial
Other
Chen F. et al, (2017), TRIALS, 18
Using optical character recognition for processing paper forms in a large randomised clinical trial
Other
Murawska A. et al, (2017), TRIALS, 18
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.
Journal article
Reith C. et al, (2017), BMC Nephrol, 18
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.
Journal article
REVEAL Collaborative Group None. et al, (2017), Am Heart J, 187, 182 - 190